- Prior was +0.2% (revised to -0.1%)
This is the worst quarter since Q4 2022.
This is the worst quarter since Q4 2022.
Most Popular
Sponsored
Bayer's $63B Monsanto buy faces 100k+ Roundup cancer suits. SCOTUS to rule on preemption.
RNST eyes earnings after strong revenue beats. Peers show mixed results, but regional banks rally 8.1%. RNST up 11.2%.
IMAX CEO sells $2.8M shares; stock up 56% YTD, P/E 21. Buy on growth?
Strategy's Bitcoin holdings gain $1.8B on paper; STRC dividend fuels buys, but share dilution is a risk.
Adidas stock jumps 1.4% on marathon record, but still down 18% YTD amid competition & tariffs.
SNAP jumps on GAAP profit potential; CRWD, FTNT, MSM see upgrades. PINS, CPB, GEV, IT, DLR face downgrades.
Real Brokerage buys Re/Max for $550M. Re/Max shares jump 70% on deal news, Real shares dip.
Sponsored
Must Read